The biological activities of disintegrins and their possible applications

Journal of Toxicology - Toxin Reviews

Volumn 16, Issue 3, 1997, Pages 135-161

  Huang, T F ^a   Liu, C Z ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COLLAGEN FIBER; DISINTEGRIN; FIBRINOGEN; INTEGRIN; MEMBRANE PROTEIN; SNAKE VENOM; TICLOPIDINE; TRIGRAMIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CLINICAL TRIAL; CONFORMATIONAL TRANSITION; DRUG DESIGN; EXTRACELLULAR MATRIX; FERTILIZATION; HEMOSTASIS; HUMAN; NONHUMAN; PROTEIN DOMAIN; REVIEW; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOSIS;

SERPENTES;

EID: 0030709254     PISSN: 07313837     EISSN: None     Source Type: Journal    
DOI: 10.3109/15569549709016452     Document Type: Review

References (121)

1. Ouyang, C., Teng, C.M. and Huang, T.F. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30: 945, 1992.
2. Teng, C.M. and Huang, T.F. Snake venom constiuents that affect platelet function. Platelets 2: 77, 1991.
3. Teng, C.M. and Huang, T.F. Inventory of exogenous inhibitors of platelet aggregation. Thrombos. Haemostas. 65: 624, 1991.
4. Gould, R.J., Polokoff, M.A., Friedman, P.A., Huang, T.P., Holt, J.C., Cook, J.C. and Niewiarowski, S. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exper. Biol. Med. 195: 168, 1990.
5. Huang, T.F. and Niewiarowski, S. Disintegrins: The naturally-occurring antagonists of platelet fibrinogen receptor. J. Toxicol. Toxin Rev. 13: 253, 1994.
6. Niewiarowski, S., McLane, M.A., Kloczewiak, M. and Stewart, G.J. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin. Hematol. 31: 289, 1994.
7. Ginsberg, M.H., Loftus, J.C., Plow, E.F. Cytoadhesion, integrins, and platelet adhesion. Thromb. Haemost. 59: 1, 1988.
8. 2+-dependent adhesion of platelets to collagen. J. Cell Biol. 108: 1917, 1989.
9. Stein, B., Fuster, V., Halperin, J.L., Chesebro, J.H: Antithrombotic therapy in cardiac disease: an emerging approach based on pathogenesis and risk. Circulation 80: 1501, 1989.
10. Coller, B.S. Platelets and thrombolytic therapy. N. Engl J. Med. 33: 322, 1990.
11. George, J.N., Caen, J.P. and Nurden, A.T. Glanzmann's thrombasthenia: the spectrum of clinical disease. Bloood 75: 1383, 1990.
12. Nieuwenhuis, H.K. Akkerman, J.W.N., Houdijk, W.P.M. and Sixma, J.J. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318: 470, 1985.
13. Nieuwenhuis, H.K., Sakariassen, K.S., Houdijk, W.P.M., Nievelstein, P.F.E.M. and Sixma, J.J. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood 68: 692, 1986.
14. Ouyang, C., Huang, T.F. Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Biochim Biophys Acta 757: 332, 1983.
15. Huang, T.F., Ouyang, C. Action mechanism of the potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Thromb. Res. 33: 125, 1984.
16. Teng, C.M., Ma, Y.H., Ouyang, C. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim Biophys Acta 841: 8, 1985.
17. Ouyang, C., Ma, Y.H., Jih, H.C. and Teng, C.M. Characterization of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim. Biophys. Acta. 841: 1, 1985.
18. Huang, T.F., Wu, Y.J. and Ouyang, C. Action mechanism of the platelet aggregation inhibitor from Calloselasma rhodostoma venom. Biochim. Biophys. Acta 925: 248, 1987.
19. Ouyang, C., Yeh, H.I. and Huang, T.F. A potent platlet aggregation inhibitor purified from Agkistrodon halys (Mamushi) snake venom. Toxicon 21: 979, 1983.
20. Huang, T.F., Yeh, H.I. and Ouyang, C. Mechanism of action of the platelet aggregation inhibitor purified from Agkistrodon halys (Mamushi) snake venom. Toxicon 22: 243, 1984.
21. Huang, T.F., Holt, J.C., Lukasiewicz, H. and Niewiarowski, S. Trigramin: A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J. Biol. Chem. 262: 16157, 1987.
22. Huang, T.F., Holt, J.C., Kirby, E.P. and Niewiarowski, S. Trigramin: Primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry 28: 661, 1989.
23. Gartner, T.J. and Bennett, J.S. The tetrapeptide analogue of cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J. Biol. Chem. 260: 1189, 1985.
24. Hynes, R.O. Integrins: a family of cell surface receptors. Cell 48: 549, 1987.
25. Huang, T.F., Liu, C.Z., Ouyang, C. and Teng, C.M. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. Biochem. Pharmacol. 42: 1209, 1991.
26. Huang, T.F., Sheu, J.R., Teng, C.M., Chen, S.W. and Liu, C.S. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb/IIIa complex. J. Biochem. 109: 328, 1991.
27. Gan, Z.R., Gould, R.J., Jacobs, J.W., Friedman, P.A. and Polokoff, M.A. Echistatin: a potent platelet aggregation inhibitor from the venom of the viper Echis carinatus. J. Biol. Chem. 263: 19827, 1988.
28. Dennis, M.S., Henzel, W.J., Pitti, R.M., Lipari, M.T., Napier, M.A., Deisher, T.A., Bunting, S. and Lazarus, R.A. Platelet glycoprotein IIb/IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc. Natl. Acad. Sci. USA 87: 2471, 1990.
29. Scarborough, R.M., Rose, J.W., Hsu, M.A. Phillips, D.R., Fried, V.A., Campbell, A.M., Nannizzi, L. and Charo, I.F. Barbourin: a GPIIb/IIIa-specific intergrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 266: 9359, 1991.
30. Cook, J.J., Huang, T.F., Rucinski, B., Stezyzewski, M., Tuma, R.F., Willioms, J.A. and Niewiarowski, S. Inhibition of platelet haemostatic plug formation by trigramin, a novel RGD-peptide. Am. J. Physiol. 256: H1038, 1989.
31. Shebuski, R.J., Ramjit, D.R., Sitko, G.R., Lumma, P.K. and Garsky, U.M. Prevention of canine coronary artery thrombosis with echistatin, a potent inhibitor of platelet aggregation from the venom of viper, Echis carinatus. Thromb. Haemost. 64: 576, 1990.
32. Yasuda, T., Gold, H.K., Leinbach, R.G., Yaoita, H., Fallon, J.T., Guerrero, L., Napier, M.A., Bunting, S. and Collen, D. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation 83: 1038, 1991.
33. Rote, W.E., Mu, D.X., Roncinske, R.A., Frelinger III, A. L. And Lucchesi, B.R. Prevention of experimental carotid artery thrombosis by applaggin. J. Pharm. Exp. Ther. 267: 809, 1993.
34. Sheu, J.R., Huang, T.F. Ex-vivo and in vivo antithrombotic effect of triflavin, an RGD-containing peptide. J. Pharm. Pharmacol. 46: 58, 1994.
35. Shigeta, O., Gluszko, P., Downing, S.W., Lu, W., Niewiarowski, S. and Edmund, W.H. Protection of platelets during long-term extracorporeal membrane oxygenation in sheep with a single dose of a disintegrin. Circulation 86: (suppl II): 398, 1992.
36. Beviglia, L., Poggi, A., Rossi, C., McLane, M.A., Cala brese, R., Scanziani, E., Cook, J.J. and Niewiarowski, S. Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins. Thromb. Res. 71: 301, 1993.
37. Frank, J.D., Gould, R.J., Schaffer, L.W., Davidson, J.T., Gibson, R.E., Patrick, D.H., Vonderfecht, S.L. and Cartwright, M.E. Immunocytochemical localizaiton of platelets in baboon hepatic sinusoids using monoclonal mouse anti-human platelet glycoprotein IIIa following iduction of thrombocytopenia. Histochemistry 97: 355, 1992.
38. Schror, K. Antiplatelet drug: a comparative review. Drugs 50: 7, 1995.
39. Pierschbacher, M.D., Ruoslahti, E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30, 1984.
40. Weller, T., Alig, L., Muller, M.H., Kouns, W.C. and Steiner, B. Fibrinogen receptor antagonists - a novel class of promising antithrombotics. Drugs Future 19: 461, 1994.
41. Gartner, T.K., Bennett, J.S. The tetrapeptide analogue of cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J. Biol Chem. 260: 11891, 1985.
42. Adler, M., Lazarus, R.A., Dennis, M.S. and Wagner, G. Solution sturcture of kistrin, a potent platelet aggregation inhibitor of GPIIb/IIIa antagonist. Science 253: 445, 1991.
43. Saudek, V., Atkinson, R.A., Pelton, J.T. Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 30: 7369, 1991.
44. Cheng, H.Y., Davis, L.L., Holl, W.W. Preparation and properties of a fibrinogen receptor antagonist containing the Arg-Gly-Asp sequence and nitroxide radicals. Bioorg Med. Chem. Lett. 3: 1179, 1993.
45. Kopple, K.D., Baures, P.W., Bean, J.W., D'Ambrosio, C.A., Hughes, J.L., Peishoff, C.E. and Eggleston, D.S. Conformations of Arg-Gly-Asp containing heterodetic cyclic peptides: solution and crystal studies. J. Am. Chem. Soc. 114: 9615, 1992.
46. Barker, P.L., Bullens, S., Bunting, S., Burdick, D.J., Chang, K.S., Deisher, T., Eigenbrot, C., Gadek, T.R., Gantzos, R., Lipari, M.T., Muir, C.D., Napier, M.A., Pitti, R.M., Padua, A., Quan, C., Stanley, M., Struble, M., Tom, J.Y.K. and Burnier, J.P. Cyclic RGD peptide analogues as antiplatelet antithrombotics. J. Med. Chem. 35: 2040, 1992.
47. Berthel, S.J., Olson, G.L. Cyclic RGD peptide analogues as antiplatelet antithrombotics. Chemtracts-Org Chem. 6: 42, 1993.
48. Lefkovits, J., Plow, E.F., Topol, E.J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N. Engl. J. Med. 332: 1553, 1995.
49. Lefkovits, J., Topol, E.J. Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease. Eur. Herat. J. 17: 9, 1996.
50. Coller, B.S. Antiplatelet agents in the prevention and therapy of thrombosis. Ann. Rev. Med. 43: 171, 1992.
51. Coller, B.S. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J. Clin. Invest. 76: 101, 1985.
52. Liu, C.Z., Wang, Y.W., Shen, M.C. and Huang, T.F. Analysis of human platelet glycoprotein IIb/IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb. Haemost. 72: 919, 1994.
53. Ault, K.A., Mitchell, J. Analysis of platelets by flow cytometry. In: Darzynkiewicz Z, Robinson, J.P., Crissman, H.A., eds. Methods in cell biology: Flow cytometry. Academic Press Inc. San Dieago, California. 42: 275, 1994.
54. Ginsberg, M.H., Frelinger, A.L., Lam, S.C., Forsyth, J., McMillan, R., Plow, E.F. and Shattil, S.J. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb/IIIa with conformation-specific monoclonal antibodies. Blood 76: 2017, 1990.
55. Shattil, S.J., Cunningham, M., Hoxie, J.A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70: 307, 1987.
56. Johnston, G.I., Heptinstall, S., Robins, R.A. and Price, M.R. The expression of glycoproteins on single blood platelet from healthy individuals and from patient with congenital bleeding disorders. Biochem. Biophys. Res. Commun 123: 1091, 1984.
57. Tschoepe, D., Spangenberg, P., Esser, J., Schwippert, B., Kehrel, B., Boesen, P. and Gries, F.A. Flow-cytometric detection of surface membrane alternations and concomitant changes in the cytoskeletal acitn status of activated platelets. Cytometry, 11: 652, 1990.
58. Jennings, L.K., Ashman, R.A., Wang, W.C. and Dockter, M.E. Analysis of human platelet glycoprotein IIb/IIIa and Glazmann's thrombasthenia in whole blood by flow cytometry. Blood 68: 173, 1986.
59. Coller, B.S., Anderson, K., Weisman, H.F. New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb. Haemost. 74: 302, 1995.
60. The EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N, Engl. J. Med. 330: 956, 1994.
61. Topol, E.J., Califf, R.M., Weisman, H.F., Ellis, S.G., Tcheng, J.E., Worley, S., Ivanhoe, R., George, B.S., Fintel, D., Weston, M., Sigmon, K., Anderson, K.M., Lee, K.L. and Willerson, J.T. Randomised trial of coronary intervation with antibody against platelet GPIIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 343: 881, 1994.
62. Yasuda, T., Gold, H.K., Fallon J.T., Leinbach, R.C., Guerrero, J.L., Scudder, L.E., Kanke, M.K., Shealy, D., Ross, M.J., Collen, D. and Coller, B.S. Monoclonal antibody against the platelet glycorpotein (GP IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J. Clin Invest 81: 1284, 1988.
63. Gold, H.K., Coller, B.S., Yasuda, T., Saito, T., Fallon, J.T., Guerrero, J.L., Leinbach, R.C. Ziskind, A.A. and Collen, D. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. Circulation 77: 670, 1988.
64. Gold, H.K., Gimple, L.W., Yasuda, T., Leinbach, R.C., Werner, W., Holt, R., Jordan, R., Berger, H., Collen, D. and Coller, B.S. Pharmacodynamic study of F (ab′) 2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris. J. Clin. Invest 86: 651, 1990.
65. Kohmura, C., Gold, H.K., Yasuda, T., Holt, R., Nedelman, M.A., Guerrero, J.L., Weisman, H.F. and Collen, D. A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons. Arterioscler Thromb. 13: 1837, 1993.
66. Kleiman, N.S., Ohman, E.M., Califf, R.M., George, B.S., Kereiakes, D., Aguirre, F.V., Weisman, H., Schaible, T. and Topol, E.J. Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy: results of the thormbolysis and angioplasty in myocardial infarction (TAMI) 8 pilot study. J. Am. Coll. Cardiol. 22: 381, 1993.
67. Tcheng, J.E., Ellis, S.G., George, B.S., Kereiakes, D.J., Kleiman, N.S., Talley, J.D., Wang, A.L., Weisman, H.F., Califf, R.M. and Topol, E.J. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation 90: 1757, 1994.
68. Coller, B.S., Scudder, L.E., Lang, D.A. A rapid, whole blood, bedside assay to monitor platelet glycoprotein (GP) IIb/IIIa blockade (abstr.). Blood 84: 474a, 1994.
69. Liu, C.Z., Peng, H.C., Huang, T.F. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis. Toxicon 33: 1289, 1995.
70. Liu, C.Z., Hur, B.T. and Huang, T.F. Measurement fo glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins. Thromb. Haemostas. 76: 585, 1996.
71. Takeya, H., Oda, K., Omori-Satoh, T. and Iwanaga, S. The complete amino acid sequence of the high molecular mass haemorrhagic protein HRIb isolated from the venom of Trimeresurus flavoviridis. J. Biol. Chem. 265: 16068, 1990.
72. Au, L.C., Huang, Y.B., Huang, T.F. and Choo, K.B. A common precursor for a putative haemorrhagic protein and rhodostomin, a platelet aggregation inhibitor of veonom Calloselasma rhodostoma: molecular cloning and sequence analysis. Biochem. Biophys. Res. Commu. 181: 585, 1991.
73. Au, L.C., Chou, J.S., Chang, K.J., Teh, G.W. and Lin, S.B. Nucleated sequence of a full-length cDNA encoding a common precursor of platelet aggregation inhibitor and haemorrhagic protein from Calloselasma rhodostoma venom. Biochim. Biophys. Acta 1173: 243, 1993.
74. Neeper, M.P. and Jacobson, M.A. Sequence of a cDNA encoding the platelet aggregation inhibitor trigramin. Nucl. Acids Res. 18: 4255, 1990.
75. Fox, J.W. and Bjarnason. The reprolysin: a family of metalloproteases defined by snake venom and mammalian metalloproteases. In Zinc Metalloproteases in Health and Disease. N. Hooper ed. Ellis Horwood/Simmon & Schuster International Group. West Sussex, England. 1995.
76. Grunwald, G.B. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr. Opin Cell Biol. 5: 797, 1993.
77. Springer, T.A. Adhesion receptors of the immune system. Nature 346: 425, 1990.
78. Bevilacqua, M., Butcher, E., Furie, B. Furie, B., Gallatin, M., Gimbrone, M., Harlan, J., Kishimoto, K., Lasky, L., McEver, R., Paulson, J., Rosen, S., Seed, B., Siegelman, M., Springe,r J., Stoolman, L., Tedder, T., Varki, A., Wagner, D., Weissman, I. and Zimmerman, G. Selectins: a family of adhesion receptors. Cell 67: 233, 1991.
79. Hynes, R.O. Integrins: versatility, modulation and signalling in cell adhesion. Cell 69: 11, 1992.
80. Wolfsberg, T.G., Primakoff, P., Myles, D.G. and White, J.M. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: Multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 131: 275, 1995.
81. Huovila, A-P.J. Almeida E.A.C. and White, J.M. ADAMs and cell fusion Curr. Opion. Cell Biol. 8: 692, 1996.
82. Blobel, C.P., Wolfsberg, T.G., Turck, C.W., Myles, D.G., Primakoff, P. and White, J.M. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature (Lond) 356: 248, 1992.
83. Wolfsburg, T.G., Bazan, J.F., Blobel, C.P., Myles, D.G., Primakoff, P. and White, J.M. The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional, and evolutimary implication. Proc. Natl. Acad. Sci. U.S.A. 90: 10783, 1993.
84. Wolfsburg, T.G., Straight, P.D., Gerena, R., Huvovila A-P. J., Primakoff, P., Myles, D.G. and White, J.M. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev. Biol. 169: 378, 1995.
85. Wassarman, P.M. Profile of a mammalian sperm receptor. Development 108: 1, 1990.
86. Perry, A.C.F., Jones, R., Barker, P.J. A mammalian epididymal protein with remarkable sequence similarity to snake venom haemorrhagic peptides. Biochem. J. 286: 671, 1992.
87. Weskamp, G., Blobel, C.P. A family of cellular proteins reated to snake venom disintegrins. Proc. Natl. Acad. Sci. U.S.A. 91: 2748, 1994.
88. Gupta, S.K., Alves, K., Palladino, L.O., Mark, G.E. and Hollis, G.F. Molecular cloning of the human fertilin β subunit. Biochem. Biophys Res Commun 224: 318, 1996.
89. Teng, C.M., Ko, F.N., Tsai, I.H., Huang, M.L. and Huang, T.F. Trimucytin a collagen-like aggregation inducer isolated from Trimeresurus mucrosquamatus snake venom. Thromb. Haemostas. 69: 286, 1993.
90. Huang, T.F., Liu, C.Z. and Yang, S.H. Aggretin, a novel platelet aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem. J. 309: 1021, 1995.
91. Zhou, Q., Smith, J.B. and Grossman, M.H. Biochem. J. 307: 411, 1995.
92. De Luca, M., Ward, C.M., Ohmori, K., Andrew, R.K. and Berndt, M.C. Biochem. Biohys. Res. Comm. 206: 570, 1995.
93. Smith, J.B., Dangelmaier, C. and Selak, M. Identification of 50kDa snake venom proteins which specifically inhibit platelet adhesion to collagen. FEBS 283: 307, 1991.
94. Liu, C.Z. and Huang, T.F. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch. Biochem. Biophys. 337: 291, 1997.
95. Zhou, Q., Dangelmaire, C. and Smith, J.B. The hemorrhagin catrocollastin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem. Biophys. Res. Comm. 219: 720, 1996.
96. Kamiguti, A.S., Hay, C.R. and Zuzel, M. Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloprotease jararhagin. Biochem J. 320: 635, 1996.
97. 3 integrins in hemostasis and vascular biology. Thromb Haemostas. 74: 149, 1995.
98. Shehiro, K., Smith, J.W. and Plow, E.F. The ligand recognition specificity of β3 integrins. J Biol Chem. 271: 10365, 1996.
99. Folkman, J. and Shing, Y. Angiogenesis. J. Biol. Chem. 267: 10931, 1992.
100. D'Amor, P.A. and Thompson, R.W. Mechanisms of angiogenesis. Annu. Rev. Physiol. 49: 453, 1987.
101. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med. 1: 27, 1995.
102. Weinstat-Saslow, D. and Steeg, P.S. Angiogenesis and colonization in the tumor metastatic process: basis and applied advances. FASEB J. 8: 401, 1994.
103. Brooks, P.C., Montgomery, A.M.P., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G. and Cheresh, D.A. Integrin alpha-V/beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood ressels. Cell 79: 1157, 199
104. Brooks, P.C., Clark, R.A.F. and Cheresh, D.A. Requirement of vascular integrin alpha-V/beta-3 for angiogenesis. Science 264: 569, 1994.
105. Brooks, P.C., Stromblad, S., Sanders, L.C., Von Schalscha, T.L., Aimes, R.T. Stetler-Stevenson, W.G., Quigley, J.P. and Cheresh, D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha-V/beta-3. Cell 85: 683, 1996.
106. Hammes, H.P., Brownlee, M., Jonczyk, A., Sutter, A. and Preissner, K.T. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Med. 2: 529, 1996.
107. Sheu, J.R., Lin, C.H. and Huang, T.F. Triflavin, an antiplatelet peptide inhibits tumor cell-extracellular matrix adhesion via an RGD-dependent mechanism. J. Lab. Clin. Med. 123: 256, 1994.
108. Chiang, H.S., Yang, R.S. and Huang, T.F. Arg-Gly-Asp containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by Saos-2 human osteosarcoma cells. Br. J. Cancer 71: 265, 1995.
109. Sheu, R.S., Lin, C.H., Peng, H.C. and Huang, T.F. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Proc Soc. Exp. Biol. Med. 213: 71, 1996.
110. 10 mouse melanoma cell adhesion to matrix proteins via direct binding to tumor cells. J. Biomed. Sci. 3: 359, 1996.
111. Sheu, J.R., Lin, C.H., Chuang, J.L., Teng, C.M. and Huang, T.F. Triflavin, an Arg-Gly-Asp containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization. Jpn J. Cancer Res. 83: 885, 1992.
112. Soszka, T., Knudsen, K.A., Beviglia, L. Rossi, C. Poggi, A. and Niewiarowski, S. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus alborabris. Exp. Cell Res. 196: 6, 1991.
113. Morris, V.L., Schmidt, E.E., Koop, S., MacDonald, I.C., Grattan, Khokka, R., McLane, M.A., Niewiarowoki, S., Chambers, A.F. and Croom, A.C. Effects of disintegin Eristostatin on individual steps of hematogenous metastasis. Exp. Cell Res. 219: 571, 1995.
114. Chang, M.C., Wang, B.R. and Huang, T.F. Characterization of endothelial cell differential attachment ot fibrin and fibrinogen and its inhibition by Arg-Gly-Asp containing peptides. Thromb. Haemostas. 74: 764, 1995.
115. 3 integrin binding and the subsequent activation of a G-protein coupled phospholipase C. Biochim Biophys. Acta 1269: 114, 1995.
116. 3 and phospholipase C regulate prostacyclin formation of endothelial cells caused by ancrod-generated fibrin. Eur. J. Pharmacol. 297: 129, 1996.
117. Moake, J.L., Turner, N.A., Stathopoulos, N.A Nolasco, L. and Hellums, J.D. Shear-induced platelet aggregation can be mediated by vWF released from platelet, as well as by exogenous large or unusually large vWF multimers, requires adensine diphosphate, and is resistant to aspirin. Blood, 71: 1366, 1988.
118. Ikeda, Y., Handa, M., kamata, K., Kawai, Y Watanabe, K., kawakami, K., Sakai, K., Fukuyama, M., Itagaki, I. and Ruggeri, Z.M. Transmembrane calcium influx associated with von Willebrand factor binding to GPIb in the initiation of shear-induced platelet aggregation. Thromb. Haemostas. 69: 496, 1993.
119. Alevridou, B.R., Moake, J.L., Turner, N.A., Ruggeri, Z.M Folie, B.J., Phillips, M.D., Schreiber, A.B., Hrinda, M.E., McIntire, L.V. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 6: 1263, 1993.
120. Savage, B., Sadlivar, E. and Ruggeri, Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84: 289, 1996.
121. Fujimura, Y., Kawasaki, T. and Titani, K. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb. Haemostas. 76: 633, 1996.